This website uses cookies. For more information please contact us or consult our privacy policy.

Your binder contains to many pages, the maxiumum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

Peter Safir
Peter O. Safir
Senior Counsel
Washington +1 202 662 5162 psafir@cov.com Download V-card

Peter Safir has been practicing in the food and drug field for over 25 years and is widely recognized in the pharmaceutical industry as one of the leading food and drug regulatory lawyers in the country.  In recent years, Mr. Safir has worked primarily with the research-based pharmaceutical industry concentrating on marketing practices, life cycle management, and issues involving drug quality and manufacturing.

  • Represented PhRMA in the drafting of the PhRMA Code on the relationship between PhRMA members and healthcare professionals.
  • Represented Johnson & Johnson in obtaining pediatric exclusivity for Duragesic and successfully defended FDA grant in the District Court and Court of Appeals.
  • Represented Pfizer in obtaining pediatric exclusivity for Diflucan and successfully defended the grant in District Court.
  • Counsel to the Independent Panel of Guidant Corporation investigating implantable defibrillators.
  • Counsel to numerous research based companies on FDA regulatory strategies.
  • The Food and Drug Law Institute, Distinguished Service and Leadership Award (2014)
  • The International Who's Who of Life Sciences Lawyers (2012)
  • PLC Life Sciences, Which Lawyer? for Regulatory (2005-2012)
  • Recognized in the Legal Times "Leading Lawyers" series as being a top food & drug attorney in Washington DC (2005-2006).
  • Named in Best Lawyers In America for his work in FDA law (2007-2014).
  • The Best Lawyers in America, Washington FDA Lawyer of the Year (2012)
  • Chosen by Chambers & Partners to appear in their Chambers USA Guide as a leading Washington, DC attorney in the field of Healthcare: Pharmaceutical/Medical Products Regulatory (2006-2015) and Life Sciences: Regulatory/Compliance (2014-2015).
  • Legal 500 US, "Leading Lawyer" - Healthcare: Life Sciences (2014)
  • Legal 500 US, Healthcare: Life Sciences (2013-2015)
  • Washington DC Super Lawyers, FDA (2012-2014) 
  • LMG Life Sciences, "Life Science Star" (2013)
  • Washingtonian, Best Lawyers (2011, 2013)
  • Named in Euromoney's Expert Guides to the World's Leading Lawyers as being a leading attorney in the healthcare field (2006).